Pruritus mediator in epidermal tissue

“Pruritus mediators in epidermal tissue” is not a single molecule or canonical therapeutic target. Instead, it refers collectively to various endogenous substances within the skin that contribute to the sensation of itch. These include **histamine** (primarily acting via H1 and H4 receptors), **endovanilloids**, **opioids**, **neurotrophins**, **cannabinoids**, **proteases**, and multiple cytokines. Histamine is well-known for its role in acute allergic reactions and urticaria through activation of G protein-coupled histamine receptors on nerve fibers. The more recently characterized histamine type 4 receptor (H4) is expressed mainly on immune cells like dendritic cells, mast cells, and eosinophils—playing roles both in allergic inflammation and pruritus itself. Other neurotransmitters such as acetylcholine can also induce itch via muscarinic M3 receptors. Because “pruritus mediators” encompasses many different molecules with diverse mechanisms—including signal transduction pathways involving immune responses and neural processing—this entry does not correspond to one discrete druggable target but rather an array of potential targets implicated across various inflammatory or allergic skin conditions[1][3].

Other names

Itch mediators in skinEpidermal pruritus mediatorsPruritogenic factors in epidermis

Varies by mediator; e.g., antihistamines block histamine receptors, H4 antagonists block H4 receptor activity.